REFERENCES
1. De Koning C, Plantinga M, Besseling P, Boelens JJ, Nierkens S. Immune Reconstitution after Allogeneic Hematopoietic Cell Transplantation in Children. Biol Blood Marrow Transplant . 2016;22:195-206. doi:10.1016/j.bbmt.2015.08.028
2. Dekker L, de Koning C, Lindemans C, Nierkens S. Reconstitution of t cell subsets following allogeneic hematopoietic cell transplantation.Cancers . 2020;12(7):1-21. doi:10.3390/cancers12071974
3. Storek J, Geddes M, Khan F, et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans.Semin Immunopathol . 2008;30(4):425-437. doi:10.1007/s00281-008-0132-5
4. Forcina A, Noviello M, Carbone MR, Bonini C, Bondanza A. Predicting the Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: The Long and Winding Road toward Validated Immune Biomarkers. Front Immunol . 2013;4:71. doi:10.3389/fimmu.2013.00071
5. Ogonek J, Juric MK, Ghimire S, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation. Front Immunol . 2016;7(NOV):1-15. doi:10.3389/fimmu.2016.00507
6. De Vries E, Van Tol MJD, Langlois Van Den Bergh R, et al. Reconstitution of lymphocyte subpopulations after paediatric bone marrow transplantation. Bone Marrow Transplant . 2000;25(3):267-275. doi:10.1038/sj.bmt.1702141
7. Kalwak K, Gorczynska E, Toporski J, et al. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery.Br J Haematol . 2002;118(1):74-89. doi:10.1046/j.1365-2141.2002.03560.x
8. Geddes M, Storek J. Immune reconstitution following hematopoietic stem-cell transplantation. Best Pract Res Clin Haematol . 2007;20(2):329-348. doi:10.1016/j.beha.2006.09.009
9. Gale RP, Seber A, Bonfim C, Pasquini M. Haematopoietic cell transplants in Latin America. Bone Marrow Transplant . 2016;51(7):898-905. doi:10.1038/bmt.2016.35
10. Bayraktar UD, Milton DR, Guindani M, et al. Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation. Biol Blood Marrow Transplant . 2016;22(3):505-513. doi:10.1016/j.bbmt.2015.10.020
11. Rigoni L, Scroferneker ML, Pitombeira BS, et al. Importance of early absolute lymphocyte count after allogeneic stem cell transplantation: A retrospective study. Transplant Proc . 2015;47(2):511-516. doi:10.1016/j.transproceed.2014.11.042
12. Yamamoto W, Ogusa E, Matsumoto K, Maruta A, Ishigatsubo Y, Kanamori H. Lymphocyte recovery on day 100 after allogeneic hematopoietic stem cell transplant predicts non-relapse mortality in patients with acute leukemia or myelodysplastic syndrome. Leuk Lymphoma . 2014;55(5):1113-1118. doi:10.3109/10428194.2013.823491
13. Bühlmann L, Buser AS, Cantoni N, et al. Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT.Bone Marrow Transplant . 2011;46(10):1357-1362. doi:10.1038/bmt.2010.306
14. Bae KW, Kim BE, Koh KN, Im HJ, Seo JJ. Factors influencing lymphocyte reconstitution after allogeneic hematopoietic stem cell transplantation in children. Korean J Hematol . 2012;47(1):44-52. doi:10.5045/kjh.2012.47.1.44
15. Kanate AS, Nagler A, Savani B. Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation. Clin Hematol Int . 2019;2(1):2-4. doi:10.2991/chi.d.191207.001
16. 1994 Consensus Conference on Acute GVHD Grading. - PubMed - NCBI. https://www.ncbi.nlm.nih.gov/pubmed/7581076. Published 1995. Accessed May 15, 2020.
17. Le Blanc K, Barrett AJ, Schaffer M, et al. Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies. Biol Blood Marrow Transplant . 2009;15(9):1108-1115. doi:10.1016/j.bbmt.2009.05.015
18. Kim HO, Oh HJ, Lee JW, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation in children: A single institution study of 59 patients. Korean J Pediatr . 2013;56(1):26-31. doi:10.3345/kjp.2013.56.1.26
19. Bartelink IH, Belitser S V., Knibbe CAJ, et al. Immune Reconstitution Kinetics as an Early Predictor for Mortality using Various Hematopoietic Stem Cell Sources in Children. Biol Blood Marrow Transplant . 2013;19(2):305-313. doi:10.1016/j.bbmt.2012.10.010
20. Storek J. Immunological reconstitution after hematopoietic cell transplantation - Its relation to the contents of the graft.Expert Opin Biol Ther . 2008;8(5):583-597. doi:10.1517/14712598.8.5.583
21. Thapa P, Farber DL. The Role of the Thymus in the Immune Response.Thorac Surg Clin . 2019;29(2):123-131. doi:10.1016/j.thorsurg.2018.12.001
22. Williams KM, Gress RE. Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.Best Pract Res Clin Haematol . 2008;21(3):579-596. doi:10.1016/j.beha.2008.06.003
23. Kuball J, Boelens JJ. Clinical and biological concepts for mastering immune reconstitution after HSCT: toward practical guidelines and greater harmonization. In: Carreras E, et al, eds. The EBMT Handbook . Springer, Cham; 2019:69-74.
24. Körbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: Does the source of hematopoietic stem cells matter? Blood . 2001;98(10):2900-2908. doi:10.1182/blood.V98.10.2900
25. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood . 2001;97(11):3380-3389. doi:10.1182/blood.V97.11.3380
26. Fedele R, Martino M, Garreffa C, et al. The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation. Blood Transfus . 2012;10(2):174-180. doi:10.2450/2012.0034-11
27. Admiraal R, van Kesteren C, Jol-van der Zijde CM, et al. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis. Lancet Haematol . 2015;2(5):e194-e203. doi:10.1016/S2352-3026(15)00045-9
28. Reddehase MJ. Mutual interference between cytomegalovirus and reconstitution of protective immunity after hematopoietic cell transplantation. Front Immunol . 2016;7. doi:10.3389/fimmu.2016.00294
29. Alexandersson A, Koskenvuo M, Tiderman A, et al. Viral infections and immune reconstitution interaction after pediatric allogenic hematopoietic stem cell transplantation. Infect Dis . 2019;51(10):772-778. doi:10.1080/23744235.2019.1650198
30. Janeczko M, Mielcarek M, Rybka B, Ryczan-Krawczyk R, Noworolska-Sauren D, Kałwak K. Immune recovery and the risk of CMV/ EBV reactivation in children post allogeneic haematopoietic stem cell transplantation. Cent Eur J Immunol . 2016;41(3):287-296. doi:10.5114/ceji.2016.63129
31. Drylewicz J, Schellens IMM, Gaiser R, et al. Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation. J Transl Med . 2016;14(1):230. doi:10.1186/s12967-016-0988-4
32. Suessmuth Y, Mukherjee R, Watkins B, et al. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood . 2015;125(25):3835-3850. doi:10.1182/blood-2015-03-631853
33. Berger M, Figari O, Bruno B, et al. Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality. Bone Marrow Transplant . 2008;41(1):55-62. doi:10.1038/sj.bmt.1705870
34. Clave E, Busson M, Douay C, et al. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood . 2009;113(25):6477-6484. doi:10.1182/blood-2008-09-176594
35. Dudakov JA, Perales MA, van den Brink MRM. Immune reconstitution following hematopoietic cell transplantation. In: Forman SJ, et al, eds.Thomas’ Hematopoietic Cell Transplantation, 5th ed. Wiley Blackwell; 2016:160-169. doi:10.1002/9781118416426.ch15
36. Luznik L, Fuchs EJ. High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res . 2010;47(1-3):65-77. doi:10.1007/s12026-009-8139-0
37. McCurdy SR, Vulic A, Symons HJ, et al. Comparable and Robust Immune Reconstitution after HLA-Haploidentical or HLA-Matched Allogeneic Transplantation (BMT) Utilizing Posttransplantation Cyclophosphamide.Biol Blood Marrow Transplant . 2015;21(2):S71. doi:10.1016/j.bbmt.2014.11.075
38. Lin CH, Su YJ, Hsu CY, Wang PN, Teng CLJ. Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia.Transpl Infect Dis . 2019;21(4). doi:10.1111/tid.13096
39. Bashey A, Zhang X, Jackson K, et al. Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 Allele-Matched Unrelated Donors and HLA-Identical Sibling Donors: A Multivariable Analysis Including Disease Risk Index.Biol Blood Marrow Transplant . 2016;22(1):125-133. doi:10.1016/j.bbmt.2015.09.002
40. Kim DH, Sohn SK, Won DI, Lee NY, Suh JS, Lee KB. Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation.Bone Marrow Transplant . 2006;37(12):1119-1128. doi:10.1038/sj.bmt.1705381